TC
IRMD icon

TFS Capital’s iRadimed IRMD Stock Holding History

TFS Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-15,846
Closed -$386K – 816
2015
Q3 		$386K Buy
+15,846
New +$379K 0.04% 605

Other funds holding IRMD

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
TCM
Tygh Capital Management Portland, Oregon $782M AUM 39.44% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

TFS Capital's IRMD Position: Q4 2015 in Review

TFS Capital sold out of iRadimed (IRMD) in Q4 2015, closing a stake of 15,846 shares — an estimated $386K sold.

TFS Capital first reported a position in IRMD in Q3 2015 and held it in 1 quarter. The position peaked at $386K in Q3 2015. 75 funds tracked by Wall St. Rank hold IRMD as of Q4 2015.

  • TFS Capital reported no remaining iRadimed position as of Q4 2015 after selling out during the quarter.
  • TFS Capital sold 15,846 iRadimed shares in Q4 2015, an estimated $386K.
  • TFS Capital first reported a position in iRadimed in Q3 2015 and held it in 1 quarter.
  • TFS Capital's iRadimed position peaked at $386K in Q3 2015.
  • 75 funds tracked by Wall St. Rank held iRadimed as of Q4 2015.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.